FAQs: <698> Deliverable Volume

As of April 11, 2022

USP provides answers to Frequently Asked Questions (FAQs) as a service to stakeholders and others who are seeking information regarding USP’s organization, standards, standards-setting process, and other activities. These are provided for informational purposes only and should not be construed as an official interpretation of USP text or be relied upon to demonstrate compliance with USP standards or requirements. USP does not endorse any specific brand or product. For questions not answered here, USP provides multiple routes of support by which the public may seek additional information. 

When should I use 698> Deliverable Volume for product testing?

The following chapters all contain methods relevant to the quantitation of the amount of dosage form contained in a package for a liquid or semisolid product.

• <697> Container Content for Injections
• <698> Deliverable Volume
• <755> Minimum Fill
• <905> Uniformity of Dosage Units

If the product is an injectable product, then <697> should apply. If the product is a liquid in a single-dose unit or gel capsule, then <905> should apply. If the product is an oral liquid, then <698> should apply. For all other cases, then <755> should apply.

How can I meet the requirements in 698> Deliverable Volume?

USP GC <698> Deliverable Volume is intended to assure that the patient receives the intended volume of the packaged contents as indicated on the product label with a variety of dosing and delivery systems for oral liquids. Other than using the testing procedures described in the chapter, you can use alternative methods to satisfy the <698> requirements per USP General Notice 6.30. Alternative and Harmonized Methods and Procedures. The requirements of this chapter can also be met by following the described testing procedures in <755> Minimum Fill to satisfy these testing requirements and account for any product holdup with the approved packaging components. Such studies may be done during development or post-development. Such an approach should be supported by study data to justify the approved fill volume target and then confirmed for each batch produced using the method described in USP GC <755> Minimum Fill.